ab38317 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab38317 は 6 報の論文で使用されています。

  • Haque I  et al. Leptin-induced ER-a-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer 18:99 (2018). PubMed: 29370782
  • Sarkar S  et al. CCN5/WISP-2 restores ER-? in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen. Oncogenesis 6:e340 (2017). Mouse . PubMed: 28530705
  • Xiao G  et al. The expression of Wnt-1 inducible signaling pathway protein-2 in astrocytoma: Correlation between pathological grade and clinical outcome. Oncol Lett 9:235-240 (2015). PubMed: 25435966
  • Chowdhury S  et al. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic ß-cells, which promotes cell proliferation and survival against streptozotocin. Endocrinology 155:1629-42 (2014). PubMed: 24552398
  • Sabbah M  et al. CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor {beta} Signaling Pathway. Mol Cell Biol 31:1459-69 (2011). IHC-P ; Human . PubMed: 21262769
  • Fritah A  et al. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol 28:1114-23 (2008). WB ; Human . PubMed: 18070926

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録